We have observed an increased neural activity in the schizophrenia-like model mice induced by anti-Nrg1 antibodies, but did not find any significant change in neural activity using both measurements after administration of NMDAR modulators in either control or schizophrenia-like model mice. The gene discussed is NRG1; the disease is schizophrenia.